DMC Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,305
| Closed | -$211K | – | 137 |
|
|
2025
Q1 | $211K | Buy |
3,305
+13
| +0.4% | +$830 | 0.17% | 115 |
|
|
2024
Q4 | $400K | Buy |
3,292
+31
| +1% | +$3.77K | 0.33% | 92 |
|
|
2024
Q3 | $407K | Sell |
3,261
-136
| -4% | -$17K | 0.33% | 93 |
|
|
2024
Q2 | $537K | Sell |
3,397
-314
| -8% | -$49.6K | 0.46% | 70 |
|
|
2024
Q1 | $480K | Sell |
3,711
-82
| -2% | -$10.6K | 0.42% | 80 |
|
|
2023
Q4 | $366K | Buy |
3,793
+496
| +15% | +$47.8K | 0.35% | 89 |
|
|
2023
Q3 | $400K | Buy |
3,297
+93
| +3% | +$11.3K | 0.37% | 79 |
|
|
2023
Q2 | $367K | Sell |
3,204
-25
| -0.8% | -$2.86K | 0.37% | 82 |
|
|
2023
Q1 | $444K | Buy |
3,229
+34
| +1% | +$4.68K | 0.45% | 71 |
|
|
2022
Q4 | $399K | Buy |
3,195
+189
| +6% | +$23.6K | 0.45% | 70 |
|
|
2022
Q3 | $330K | Buy |
3,006
+249
| +9% | +$27.3K | 0.4% | 74 |
|
|
2022
Q2 | $209K | Buy |
2,757
+112
| +4% | +$8.49K | 0.25% | 100 |
|
|
2022
Q1 | $202K | Buy |
+2,645
| New | +$202K | 0.23% | 103 |
|